BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28919008)

  • 1. Immunoadsorption in neurological disorders.
    Oji S; Nomura K
    Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
    Hohenstein B; Passauer J; Ziemssen T; Julius U
    Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic Apheresis in Neurological Disorders].
    Nakatsuji Y
    Brain Nerve; 2021 May; 73(5):425-430. PubMed ID: 34006672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in neurological disease.
    Osman C; Jennings R; El-Ghariani K; Pinto A
    Pract Neurol; 2020 Apr; 20(2):92-99. PubMed ID: 31300488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption for autoimmune encephalitis.
    Fassbender C; Klingel R; Köhler W
    Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal antibody elimination in neuroimmunological diseases.
    Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
    Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic plasma exchange: applications in neurology].
    Láinez-Andrés JM; Gascón-Giménez F; Coret-Ferrer F; Casanova-Estruch B; Santonja JM
    Rev Neurol; 2015 Feb; 60(3):120-31. PubMed ID: 25624088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of Therapeutic Apheresis in Neurological Disease.
    Strasser E
    Transfus Med Hemother; 2023 Apr; 50(2):88-97. PubMed ID: 37066058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
    Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
    Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
    Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
    Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
    Boedecker SC; Luessi F; Engel S; Kraus D; Klimpke P; Holtz S; Meinek M; Marczynski P; Weinmann A; Weinmann-Menke J
    J Clin Apher; 2022 Feb; 37(1):70-81. PubMed ID: 34904748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre.
    Das J; Chauhan VD; Mills D; Johal NJ; Tan M; Matthews R; Keh R; Lilleker JB; Gosal D; Sharaf N
    Transfus Apher Sci; 2019 Dec; 58(6):102654. PubMed ID: 31648858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan immunoadsorption for the treatment of autoimmune encephalitis.
    Köhler W; Ehrlich S; Dohmen C; Haubitz M; Hoffmann F; Schmidt S; Klingel R; Kraft A; Neumann-Haefelin T; Topka H; Stich O; Baumgartner A; Fassbender C
    Eur J Neurol; 2015 Jan; 22(1):203-6. PubMed ID: 24589025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.
    Bambauer R; Latza R; Burgard D; Schiel R
    Ther Apher Dial; 2017 Feb; 21(1):6-21. PubMed ID: 28078733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.